share_log

Cybin Acquires DMT Clinical Study From Entheon Biomedical For C$1M

Cybin Acquires DMT Clinical Study From Entheon Biomedical For C$1M

Cybin以100万加元从Entheon Biomedical公司收购DMT临床研究
Benzinga Real-time News ·  2022/06/07 08:10

Cybin Acquires DMT Clinical Study From Entheon Biomedical For C$1M

Cybin以100万加元从Entheon Biomedical公司收购DMT临床研究

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发